Celldex Therapeutics, Inc.

VOYA INVESTMENT MANAGEMENT LLC CLDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

11,987

Value ($000)

326

Weight

0.0%

2021 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	326	0.0%	11,987	12/31/2025
2025 Q3	10/9/2025	310	0.0%	11,987	9/30/2025
2025 Q2	8/14/2025	362	0.0%	17,801	6/30/2025
2025 Q1	5/15/2025	319	0.0%	17,603	3/31/2025
2024 Q4	5/2/2025	492	0.0%	19,468	12/31/2024
2024 Q3	2/7/2025	714	0.0%	21,008	9/30/2024
2024 Q2	2/7/2025	796	0.0%	21,515	6/30/2024
2024 Q1	2/7/2025	824	0.0%	19,630	3/31/2024
2023 Q4	2/7/2025	737	0.0%	18,581	12/31/2023
2023 Q3	2/7/2025	512	0.0%	18,607	9/30/2023
2023 Q2	2/7/2025	624	0.0%	18,393	6/30/2023
2023 Q1	2/7/2025	629	0.0%	17,481	3/31/2023
2022 Q4	2/7/2025	786	0.0%	17,630	12/31/2022
2022 Q3	2/7/2025	496	0.0%	17,630	9/30/2022
2022 Q2	8/15/2022	475	0.0%	17,630	6/30/2022
2022 Q1	5/16/2022	612	0.0%	17,976	3/31/2022
2021 Q4	2/14/2022	695	0.0%	17,976	12/31/2021
2021 Q3	11/15/2021	963	0.0%	17,831	9/30/2021
2021 Q2	8/16/2021	516	0.0%	15,441	6/30/2021